People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medexus Pharmaceuticals Inc. | — | Pharmaceuticals | Pre-Seed | $400K | $18.9M | 2020 |
| Cross Bible, Inc. | — | Other Technology | Pre-Seed | $132K | $408K | 2025 |
Stephen Nelson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Nelson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Mueller | 1 | 5 |
| Peter Van Der Velden | 1 | 3 |
| Roland Boivin | 1 | 2 |
| Benoit Gravel | 1 | 2 |
| Ken d'Entremont | 1 | 1 |
| Adele Gulfo | 1 | 1 |
| Terri Shoemaker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.